04/07-2012 08:10:00: (CLAVIS) Clavis Pharma ASA : Mandatory notification of trade

J&J Future Invest AS, a company partly owned by Hilde Furberg, a board member of
Clavis Pharma ASA, has bought 3,500 shares at an average price of NOK 58.00.


After this transaction J&J Future Invest AS owns 3,500 shares in Clavis Pharma
ASA.

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.



This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: Clavis Pharma ASA via Thomson Reuters ONE
[HUG#1624002]

Nyheten er levert av Thomson Reuters ONE.